1. PPAR-γ Modulators as Current and Potential Cancer Treatments
   Tiange Chi et al, 2021, Frontiers in Oncology CrossRef
2. Current status and future prospects of molecular hybrids with thiazolidinedione (TZD) scaffold in anticancer drug discovery
   Kalpana Tilekar et al, 2022, Journal of Molecular Structure CrossRef
3. GPx3 knockdown inhibits the proliferation and DNA synthesis and enhances the early apoptosis of human spermatogonial stem cells via mediating CXCL10 and cyclin B1
   Si Wu et al, 2023, Frontiers in Cell and Developmental Biology CrossRef
4. PPAR-Mediated Toxicology and Applied Pharmacology
   Yue Xi et al, 2020, Cells CrossRef
5. The Influence of Anti-Diabetic Drugs on Prostate Cancer
   Miłosz Knura et al, 2021, Cancers CrossRef
6. Research Progress of PPARγ in Prostate Cancer
   耀 常, 2023, Advances in Clinical Medicine CrossRef
7. Lobeglitazone, A Peroxisome Proliferator-Activated Receptor-Gamma Agonist, Inhibits Papillary Thyroid Cancer Cell Migration and Invasion by Suppressing p38 MAPK Signaling Pathway
   Jun-Qing Jin et al, 2021, Endocrinology and Metabolism CrossRef
8. Insights into the role of GPX3, a highly efficient plasma antioxidant, in cancer
   Snehal Nirgude et al, 2021, Biochemical Pharmacology CrossRef